Skip to Content


In the US, Pegfilgrastim (pegfilgrastim systemic) is a member of the drug class colony stimulating factors and is used to treat Neutropenia Associated with Chemotherapy and Neutropenia Associated with Radiation.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Therapeutic Categories


Colony stimulating factor, granulocyte, G-CSF

Treatment of acute radiation syndrome (ARS)

Chemical Name

Colony-stimulating factor (human), 3-hydroxypropyl-N-metionyl-, 1-eter wit alpha-metyl-omega-hydroxypoly(oxy-1,2-etanediyl)

Foreign Names

  • Pegfilgrastimum (Latin)
  • Pegfilgrastim (German)
  • Pegfilgrastime (French)
  • Pegfilgrastim (Spanish)

Generic Names

  • Pegfilgrastim (OS: BAN, USAN)
  • Filgrastim SD01 (IS)
  • G-CSF (IS)
  • GM-CSF (IS)
  • PEG-GCS (IS)
  • PEG-granulocyte-colony stimulating factor (IS)
  • rhG-CSF (IS)
  • rhGM-CSF (IS)
  • SD 01 (IS)
  • SD Neupogen (IS)

Brand Names

  • Fillif-PEG
    Torrent, India
  • Geneleukim
    Geneleuk Biopharmaceutical, China
  • Jiexin
    Zhongkai, China
  • Neulasta
    Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Hungary; Amgen, Iceland; Amgen, Lithuania; Amgen, Latvia; Amgen, Norway; Amgen, Portugal; Amgen, Romania; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Austria, Austria; Amgen Dompè, Italy; Amgen Europe, Denmark; Amgen Europe, Croatia (Hrvatska); Amgen Europe, Netherlands; Amgen Europe, Poland; Amgen Ltd., Ireland; Amgen Switzerland, Switzerland; Inopha, Austria; Kyowa Hakko Kirin, South Korea
  • Neulastim
    Amgen, Hong Kong; Amgen Europa, Israel; F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche, Bosnia & Herzegowina; Roche, United Arab Emirates; Roche, Armenia; Roche, Netherlands Antilles; Roche, Argentina; Roche, Aruba; Roche, Azerbaijan; Roche, Bahrain; Roche, Belarus; Roche, Colombia; Roche, Ecuador; Roche, Georgia; Roche, Indonesia; Roche, Jamaica; Roche, Kenya; Roche, Kuwait; Roche, Kazakhstan; Roche, Sri Lanka; Roche, Morocco; Roche, Moldova; Roche, Mexico; Roche, Nepal; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Pakistan; Roche, Paraguay; Roche, Thailand; Roche, Trinidad & Tobago; Roche, Ukraine; Roche, Uruguay; Roche, Uzbekistan; Roche, Venezuela; Roche, Vietnam; Roche, Yemen; Roche, South Africa; Tecnofarma, Chile
  • Neupopeg
    Amgen, Lithuania
  • Pegcyte
    Nanogen Pharma, Myanmar
  • Peg-Grafeel
    Dr Reddy's, Vietnam
  • Peglasta
    Kyowa Hakko Kirin, Thailand


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.